Puumala and Andes Orthohantaviruses Cause Transient Protein Kinase R-Dependent Formation of Stress Granules.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
17 01 2020
Historique:
received: 18 07 2019
accepted: 06 11 2019
pubmed: 15 11 2019
medline: 24 7 2020
entrez: 15 11 2019
Statut: epublish

Résumé

Virus infection frequently triggers host cell stress signaling resulting in translational arrest; as a consequence, many viruses employ means to modulate the host stress response. Hantaviruses are negative-sense, single-stranded RNA viruses known to inhibit host innate immune responses and apoptosis, but their impact on host cell stress signaling remains largely unknown. In this study, we investigated activation of host cell stress responses during hantavirus infection. We show that hantavirus infection causes transient formation of stress granules (SGs) but does so in only a limited proportion of infected cells. Our data indicate some cell type-specific and hantavirus species-specific variability in SG prevalence and show SG formation to be dependent on the activation of protein kinase R (PKR). Hantavirus infection inhibited PKR-dependent SG formation, which could account for the transient nature and low prevalence of SG formation observed during hantavirus infection. In addition, we report only limited colocalization of hantaviral proteins or RNA with SGs and show evidence indicating hantavirus-mediated inhibition of PKR-like endoplasmic reticulum (ER) kinase (PERK).

Identifiants

pubmed: 31723021
pii: JVI.01168-19
doi: 10.1128/JVI.01168-19
pmc: PMC7000972
pii:
doi:

Substances chimiques

Viral Proteins 0
EIF2AK2 protein, human EC 2.7.11.1
eIF-2 Kinase EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

PLoS Comput Biol. 2015 Jun 26;11(6):e1004326
pubmed: 26115353
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
Mol Biol Cell. 2012 Dec;23(24):4701-12
pubmed: 23087212
Virology. 2013 Feb 20;436(2):255-67
pubmed: 23290869
Cell Host Microbe. 2011 Apr 21;9(4):299-309
pubmed: 21501829
Nat Rev Microbiol. 2013 Aug;11(8):539-50
pubmed: 24020072
J Cell Biol. 2005 Jun 20;169(6):871-84
pubmed: 15967811
Mol Biol Cell. 2005 Aug;16(8):3753-63
pubmed: 15930128
Arch Virol. 2002 Apr;147(4):665-82
pubmed: 12038679
Biochemistry. 2011 May 31;50(21):4550-60
pubmed: 21526770
Mol Cell. 2009 Dec 25;36(6):932-41
pubmed: 20064460
EMBO J. 2008 Dec 3;27(23):3129-39
pubmed: 18971945
Mol Cell. 2017 Nov 16;68(4):808-820.e5
pubmed: 29129640
Am J Transl Res. 2009 Jul 15;1(4):367-80
pubmed: 19956449
Cell Host Microbe. 2012 Jul 19;12(1):71-85
pubmed: 22817989
J Gen Virol. 2011 May;92(Pt 5):1199-204
pubmed: 21289157
J Virol. 2015 Mar;89(5):2575-89
pubmed: 25520508
J Virol. 2013 Jan;87(2):912-22
pubmed: 23135723
RNA Biol. 2014;11(8):1019-30
pubmed: 25531407
J Virol. 2015 Feb;89(3):1628-39
pubmed: 25410857
J Gen Virol. 2011 Sep;92(Pt 9):2191-200
pubmed: 21632559
RNA. 2000 Apr;6(4):563-70
pubmed: 10786847
Nature. 2018 Apr;556(7700):197-202
pubmed: 29618816
Trends Biochem Sci. 2015 Oct;40(10):552-559
pubmed: 26410596
Virology. 2005 Mar 1;333(1):180-9
pubmed: 15708603
Sci Rep. 2017 Jun 13;7(1):3335
pubmed: 28611419
Sci Rep. 2017 Nov 23;7(1):16129
pubmed: 29170442
J Biol Chem. 2000 Dec 1;275(48):37993-8
pubmed: 10988289
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19294-9
pubmed: 19047634
Mol Cell. 2007 Mar 9;25(5):635-46
pubmed: 17349952
J Virol. 2012 Jul;86(14):7520-9
pubmed: 22553339
Cell. 2018 Jan 25;172(3):590-604.e13
pubmed: 29373831
Cell Rep. 2019 May 14;27(7):2075-2091.e5
pubmed: 31091447
PLoS One. 2012;7(1):e28568
pubmed: 22253692
Cell Host Microbe. 2007 Nov 15;2(5):295-305
pubmed: 18005751
Clin Microbiol Rev. 2010 Apr;23(2):412-41
pubmed: 20375360
J Virol. 2015 Sep;89(18):9383-92
pubmed: 26136565
J Virol. 2010 Sep;84(18):9140-8
pubmed: 20592090
Mol Biol Cell. 2007 Jul;18(7):2603-18
pubmed: 17475769
Viruses. 2009 Dec;1(3):523-44
pubmed: 21994559
FASEB J. 2012 Apr;26(4):1629-39
pubmed: 22202676
J Virol. 2011 Sep;85(17):8884-93
pubmed: 21697471
EMBO J. 1998 Aug 3;17(15):4379-90
pubmed: 9687506
Cell. 2013 Jun 20;153(7):1461-74
pubmed: 23791177
PLoS One. 2012;7(8):e43031
pubmed: 22912779
J Virol. 2006 May;80(10):5059-64
pubmed: 16641297
J Intern Med. 2019 May;285(5):510-523
pubmed: 30663801
J Gen Virol. 1991 Sep;72 ( Pt 9):2097-103
pubmed: 1716651

Auteurs

Wanda Christ (W)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Janne Tynell (J)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden janne.tynell@ki.se.

Jonas Klingström (J)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH